age
float64 18
102
| sex
stringclasses 2
values | hospdead
int64 0
1
| slos
int64 3
343
| dzgroup
stringclasses 8
values | dzclass
stringclasses 4
values | num.co
int64 0
9
| edu
float64 0
31
⌀ | income
stringclasses 4
values | scoma
float64 0
100
⌀ | charges
float64 1.17k
1.44M
⌀ | totcst
float64 0
633k
⌀ | totmcst
float64 -102.72
711k
⌀ | avtisst
float64 1
83
⌀ | race
stringclasses 5
values | sps
float64 0.2
99.2
⌀ | aps
float64 0
143
⌀ | surv2m
float64 0
0.97
⌀ | surv6m
float64 0
0.95
⌀ | hday
int64 1
148
| diabetes
int64 0
1
| dementia
int64 0
1
| ca
stringclasses 3
values | prg2m
float64 0
1
⌀ | prg6m
float64 0
1
⌀ | dnr
stringclasses 3
values | dnrday
float64 -88
285
⌀ | meanbp
float64 0
195
⌀ | wblc
float64 0
200
⌀ | hrt
float64 0
300
⌀ | resp
float64 0
90
⌀ | temp
float64 31.7
41.7
⌀ | pafi
float64 12
890
⌀ | alb
float64 0.4
29
⌀ | bili
float64 0.1
63
⌀ | crea
float64 0.1
21.5
⌀ | sod
float64 110
181
⌀ | ph
float64 6.83
7.77
⌀ | glucose
float64 0
1.09k
⌀ | bun
float64 1
300
⌀ | urine
float64 0
9k
⌀ | adlp
float64 0
7
⌀ | adls
float64 0
7
⌀ | sfdm2
stringclasses 5
values | adlsc
float64 0
7.07
| event_times
int64 3
2.03k
| event_indicators
int64 0
1
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
75.51794
|
male
| 0
| 6
|
Colon Cancer
|
Cancer
| 1
| 8
|
$11-$25k
| 0
| 2,927
| 2,886.5352
| 0
| 12
|
white
| 13.699219
| 20
| 0.840942
| 0.651978
| 1
| 0
| 0
|
metastatic
| null | null |
dnr after sadm
| 1
| 112
| null | 73
| 16
| 37
| null | null | null | 1
| 136
| null | null | null | null | 2
| null | null | 1.839
| 77
| 1
|
79.17297
|
female
| 0
| 9
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 8
|
under $11k
| 26
| 10,831
| 8,347.8672
| 0
| 22.5
|
white
| 19.898438
| 38
| 0.745972
| 0.665894
| 1
| 0
| 0
|
no
| 0.9
| 0.75
|
no dnr
| 9
| 73
| 11.298828
| 120
| 28
| 38
| 272.5
| 2.799805
| 0.299988
| 1
| 138
| 7.089844
| null | null | null | 1
| 1
|
<2 mo. follow-up
| 1
| 56
| 1
|
52.45398
|
male
| 0
| 5
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 11
|
$11-$25k
| 0
| 4,430
| 3,420.4375
| 0
| 11
|
white
| 14.398438
| 24
| 0.930908
| 0.881958
| 1
| 0
| 0
|
no
| 0.75
| 0.75
|
no dnr
| 5
| 59
| 6.699219
| 46
| 24
| 36
| null | 4.299805
| 0.399963
| 1.199951
| 137
| null | null | null | null | 0
| 1
|
no(M2 and SIP pres)
| 1
| 1,980
| 0
|
47.978
|
male
| 0
| 4
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 16
|
$25-$50k
| 0
| 2,944
| 2,810.1133
| 0
| 14
|
white
| 17.898438
| 18
| 0.916992
| 0.860962
| 1
| 0
| 0
|
no
| 0.9
| 0.7
|
no dnr
| 4
| 60
| null | 67
| 16
| 36.29688
| null | null | null | 1.399902
| 132
| null | null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 1,980
| 0
|
78.09998
|
female
| 0
| 8
|
COPD
|
COPD/CHF/Cirrhosis
| 1
| 12
| null | 0
| 4,045
| 3,967.3262
| 0
| 5.5
|
white
| 16.597656
| 27
| 0.840942
| 0.738892
| 1
| 0
| 0
|
no
| 0.95
| 0.85
|
no dnr
| 8
| 77
| 7.199219
| 74
| 28
| 36.19531
| 336
| 3.399902
| 0.099991
| 0.799927
| 137
| 7.379883
| null | null | null | 1
| 1
|
no(M2 and SIP pres)
| 1
| 185
| 1
|
64.40198
|
male
| 0
| 17
|
Lung Cancer
|
Cancer
| 2
| 13
|
$11-$25k
| 0
| 11,896
| 9,567.375
| 0
| 12.666664
|
white
| 13.699219
| 14
| 0.769897
| 0.522949
| 1
| 0
| 0
|
metastatic
| 0.9
| 0.2
|
no dnr
| 17
| 76
| null | 74
| 20
| 36.59375
| null | null | null | null | 140
| null | null | null | null | null | null |
<2 mo. follow-up
| 2.886719
| 23
| 1
|
52.57797
|
female
| 0
| 8
|
Lung Cancer
|
Cancer
| 1
| 12
|
$11-$25k
| 0
| 3,866
| 3,825.4043
| 0
| 11.5
|
white
| 21.796875
| 21
| 0.634888
| 0.324951
| 1
| 0
| 0
|
metastatic
| 0.5
| 0.25
|
dnr after sadm
| 1
| 100
| 23.5
| 68
| 26
| 35.39844
| 280.9375
| 2.799805
| 0.5
| 0.899902
| 137
| 7.529297
| null | null | null | 5
| 4
|
<2 mo. follow-up
| 4
| 17
| 1
|
64.112
|
male
| 0
| 3
|
Colon Cancer
|
Cancer
| 2
| 12
|
under $11k
| 0
| 9,439
| 6,126.6133
| 0
| 24
|
white
| 17.199219
| 17
| 0.816895
| 0.60498
| 1
| 1
| 0
|
metastatic
| 0.95
| 0.5
|
no dnr
| 3
| 70
| 8.798828
| 56
| 20
| 36.19531
| null | null | null | 1.199951
| 137
| null | null | null | null | 0
| 2
|
no(M2 and SIP pres)
| 2
| 895
| 1
|
35.25497
|
male
| 0
| 12
|
CHF
|
COPD/CHF/Cirrhosis
| 1
| 12
|
$11-$25k
| 0
| 9,425
| 8,858.6172
| 0
| 11.5
|
white
| 16.398438
| 9
| 0.94397
| 0.903931
| 1
| 0
| 0
|
no
| 1
| 0.9
|
no dnr
| 12
| 110
| 7.099609
| 71
| 20
| 36
| 300
| 3.299805
| 0.699951
| 1.199951
| 138
| 7.469727
| null | null | null | 0
| null |
no(M2 and SIP pres)
| 0.4948
| 1,978
| 0
|
75.08795
|
female
| 0
| 6
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 1
| 12
| null | 0
| 2,721
| 2,737.4766
| 0
| 7
|
white
| 18.398438
| 18
| 0.723999
| 0.56897
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 6
| 97
| 4.399414
| 80
| 24
| 36.59375
| null | 2.799805
| 4.699219
| 0.699951
| 141
| null | null | null | null | 3
| null |
no(M2 and SIP pres)
| 2.511099
| 188
| 1
|
61.16098
|
male
| 0
| 12
|
Lung Cancer
|
Cancer
| 1
| 12
|
$11-$25k
| 0
| 5,474
| 5,262.7461
| 0
| 12
|
white
| 19.199219
| 20
| 0.671997
| 0.372986
| 1
| 0
| 0
|
metastatic
| 0.1
| 0.001
|
no dnr
| 12
| 113
| 3.399902
| 96
| 24
| 35.89844
| 392.5625
| null | null | 1.599854
| 137
| 7.489258
| null | null | null | 2
| 5
|
<2 mo. follow-up
| 5
| 24
| 1
|
60.62399
|
male
| 0
| 6
|
Lung Cancer
|
Cancer
| 1
| 12
|
$25-$50k
| 0
| 3,184
| 3,054.2676
| 0
| 6
|
white
| 16.597656
| 19
| 0.725952
| 0.452942
| 1
| 0
| 0
|
metastatic
| 0.9
| 0.9
|
no dnr
| 6
| 78
| null | 63
| 16
| 36.29688
| null | null | null | 1.399902
| 138
| null | null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 1,973
| 0
|
38.18997
|
female
| 0
| 5
|
Lung Cancer
|
Cancer
| 1
| 11
|
$11-$25k
| 0
| 3,008
| 2,698.291
| 0
| 7
|
white
| 15.099609
| 6
| 0.794922
| 0.566895
| 1
| 0
| 0
|
metastatic
| 1
| 1
|
no dnr
| 5
| 97
| null | 93
| 16
| 36.59375
| null | null | null | 0.899902
| 140
| null | null | null | null | 3
| 0
|
no(M2 and SIP pres)
| 0
| 274
| 1
|
60.52298
|
male
| 0
| 5
|
Lung Cancer
|
Cancer
| 2
| 12
|
$25-$50k
| 0
| 3,019
| 2,819.0898
| 0
| 9
|
white
| 21.199219
| 25
| 0.628906
| 0.317993
| 1
| 0
| 0
|
metastatic
| 0.9
| 0.5
|
no dnr
| 5
| 103
| null | 118
| 28
| 37
| null | null | null | 0.899902
| 133
| null | null | null | null | 1
| null |
no(M2 and SIP pres)
| 1.1669
| 146
| 1
|
63.52597
|
female
| 0
| 19
|
Lung Cancer
|
Cancer
| 2
| 14
|
>$50k
| 0
| 9,732
| 9,939.6406
| 0
| 7
|
white
| 18.296875
| 15
| 0.684937
| 0.391968
| 1
| 0
| 0
|
metastatic
| 0.9
| 0.6
|
no dnr
| 19
| 102
| 6
| 64
| 24
| 35.89844
| null | 3.399902
| 0.399963
| 0.699951
| 137
| null | null | null | null | 1
| 2
| null | 2
| 71
| 1
|
51.62997
|
female
| 0
| 21
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 12
| null | 0
| 26,097
| 21,064.1406
| 0
| 24.333328
|
white
| 19.199219
| 23
| 0.893921
| 0.855957
| 1
| 0
| 0
|
no
| 0.9
| 0.75
|
no dnr
| 21
| 62
| 14.099609
| 81
| 20
| 35.79688
| 252
| 5.199219
| 0.299988
| 1
| 131
| 7.429688
| null | null | null | null | null | null | 2.212402
| 195
| 1
|
53.24799
|
male
| 0
| 16
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 9
|
$11-$25k
| 9
| 31,599
| 24,138.4062
| 0
| 20.666656
|
white
| 24.398438
| 27
| 0.782959
| 0.712891
| 5
| 0
| 0
|
no
| 0.75
| 0.75
|
dnr after sadm
| 13
| 129
| 16.5
| 99
| 28
| 37.79688
| 145.4375
| null | null | 0.899902
| 134
| 7.449219
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 18
| 1
|
69.23798
|
male
| 0
| 12
|
Lung Cancer
|
Cancer
| 1
| null | null | 0
| 5,094
| 4,922.6289
| 0
| 9
|
white
| 19.296875
| 7
| 0.648926
| 0.34198
| 1
| 0
| 0
|
metastatic
| null | null |
dnr after sadm
| 1
| 83
| null | 107
| 20
| 36.09375
| null | null | null | 0.799927
| 137
| null | null | null | null | null | null | null | 2.822754
| 529
| 1
|
64.08997
|
female
| 1
| 9
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 12
|
under $11k
| 0
| 25,603
| 17,680.8281
| 0
| 43
|
white
| 22.199219
| 20
| 0.81189
| 0.748901
| 3
| 0
| 0
|
no
| null | null |
dnr after sadm
| 5
| 119
| 21.199219
| 106
| 10
| 36.89844
| 260
| 2.599609
| 0.399963
| 1.399902
| 130
| 7.459961
| null | null | null | null | 3
|
<2 mo. follow-up
| 3
| 9
| 1
|
71.56696
|
male
| 0
| 8
|
COPD
|
COPD/CHF/Cirrhosis
| 1
| 12
|
under $11k
| 37
| 7,708
| 6,010.5898
| 0
| 26.5
|
white
| 22.199219
| 24
| 0.690918
| 0.523926
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 8
| 97
| 16.199219
| 104
| 16
| 37.59375
| 116
| 4.199219
| 1
| 1.599854
| 137
| 7.429688
| null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 1,964
| 0
|
64.64899
|
male
| 0
| 13
|
Lung Cancer
|
Cancer
| 4
| 13
|
$11-$25k
| 0
| 7,133
| 6,788.6484
| 0
| 12
|
white
| 16.699219
| 8
| 0.714966
| 0.435974
| 1
| 0
| 0
|
metastatic
| 0.8
| 0.2
|
no dnr
| 13
| 82
| null | 96
| 16
| 36.29688
| null | null | null | 1
| 135
| null | null | null | null | null | 0
| null | 0
| 75
| 1
|
33.03497
|
male
| 0
| 24
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 12
|
under $11k
| 44
| 34,366
| 25,804.8906
| 0
| 27.666656
|
white
| 25
| 46
| 0.790894
| 0.7229
| 1
| 0
| 0
|
no
| 0.1
| 0.001
|
no dnr
| 24
| 63
| 11
| 168
| 40
| 39.39844
| 250
| 2.099609
| 0.099991
| 0.599976
| 136
| 7.479492
| null | null | null | null | 4
|
adl>=4 (>=5 if sur)
| 4
| 1,958
| 0
|
37.84799
|
male
| 1
| 60
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 20
|
$25-$50k
| 0
| 153,931
| 108,927.438
| 21,095.6094
| 47.75
|
white
| 35.59375
| 60
| 0.352966
| 0.235992
| 9
| 0
| 0
|
yes
| null | null |
dnr after sadm
| 55
| 107
| 0.899902
| 112
| 12
| 39.39844
| 232.5
| 3.299805
| 4.799805
| 6.5
| 141
| 7.40918
| null | null | null | null | 4
| null | 4
| 60
| 1
|
72.54999
|
male
| 0
| 47
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 13
|
under $11k
| 9
| 7,980
| 58,163.2188
| 2,981.35938
| 38.75
|
white
| 28.199219
| 52
| 0.634888
| 0.532959
| 3
| 0
| 0
|
no
| 0.2
| 0.2
|
no dnr
| 47
| 62
| 23.796875
| 130
| 10
| 36.69531
| 198
| 2.099609
| 4.799805
| 1.5
| 142
| 7.399414
| null | null | null | null | 1
|
no(M2 and SIP pres)
| 1
| 1,956
| 0
|
47.15399
|
female
| 0
| 6
|
Lung Cancer
|
Cancer
| 1
| 12
|
$25-$50k
| 0
| 1,495
| 1,585.3633
| 0
| 8
|
white
| 14.898438
| 12
| 0.782959
| 0.545898
| 1
| 0
| 0
|
metastatic
| null | null |
no dnr
| 6
| 74
| 3.699707
| 104
| 16
| 36.89844
| null | 3.599609
| 0.399963
| 1.099854
| 137
| null | null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 130
| 1
|
46.74298
|
male
| 0
| 5
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 4
| 15
|
$11-$25k
| 0
| 4,862
| 3,947.4746
| 0
| 6
|
white
| 22.597656
| 22
| 0.822998
| 0.711914
| 1
| 1
| 0
|
no
| null | null |
no dnr
| 5
| 63
| 6.099609
| 51
| 24
| 36.09375
| 361.875
| 3.599609
| 3.199707
| 0.599976
| 135
| 7.419922
| null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 484
| 1
|
66.69397
|
female
| 1
| 17
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| null | null | 0
| 50,034
| 35,662.0938
| 0
| 34.333313
|
white
| 33.296875
| 66
| 0.451965
| 0.33197
| 10
| 0
| 0
|
yes
| 0.75
| 0.5
|
no dnr
| 17
| 67
| 10.798828
| 156
| 8
| 37.79688
| 116
| null | null | 2.299805
| 132
| 7.589844
| null | null | null | null | null |
<2 mo. follow-up
| 2.143555
| 17
| 1
|
71.24695
|
male
| 1
| 4
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 12
|
under $11k
| 0
| 11,031
| 7,678.4141
| 0
| 55
|
white
| 28.796875
| 42
| 0.699951
| 0.608887
| 1
| 0
| 0
|
no
| 0
| 0
|
dnr after sadm
| 4
| 63
| 7.099609
| 98
| 12
| 39.59375
| 150
| 2.899902
| 0.899902
| 7.699219
| 129
| 7.419922
| null | null | null | null | null |
<2 mo. follow-up
| 2.087891
| 4
| 1
|
74.78998
|
female
| 1
| 213
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 12
| null | 0
| 305,357
| 240,289.875
| 160,055.5
| 45.25
|
white
| 24.597656
| 25
| 0.611938
| 0.505981
| 22
| 1
| 0
|
yes
| 0.5
| 0.5
|
dnr after sadm
| 15
| 63
| 18.199219
| 106
| 12
| 38
| 120
| 2.599609
| 0.699951
| 0.799927
| 142
| 7.469727
| null | null | null | null | 0
|
adl>=4 (>=5 if sur)
| 0
| 213
| 1
|
59.32098
|
male
| 0
| 6
|
COPD
|
COPD/CHF/Cirrhosis
| 1
| 8
|
$11-$25k
| 0
| 3,759
| 3,812.2266
| 0
| 7
|
white
| 19.796875
| 43
| 0.888916
| 0.814941
| 1
| 0
| 0
|
no
| 0.05
| 0.000125
|
dnr after sadm
| 1
| 111
| 5.799805
| 122
| 32
| 36.69531
| 160.84375
| 4.099609
| 0.299988
| 1.099854
| 140
| 7.449219
| null | null | null | 4
| 6
|
<2 mo. follow-up
| 6
| 7
| 1
|
33.19397
|
male
| 0
| 12
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| null |
under $11k
| 0
| 11,717
| 9,524.1484
| 0
| 20.5
|
white
| 29.699219
| 31
| 0.831909
| 0.774902
| 1
| 0
| 0
|
no
| 0.9
| 0.9
|
no dnr
| 12
| 99
| 11.298828
| 118
| 36
| 38.59375
| 98.32812
| 3
| 0.5
| 0.799927
| 139
| 7.30957
| null | null | null | null | 7
|
adl>=4 (>=5 if sur)
| 7
| 1,253
| 1
|
54.31897
|
female
| 1
| 6
|
Coma
|
Coma
| 0
| 12
|
$11-$25k
| 89
| 10,406
| 7,773.2188
| 0
| 35
|
white
| 22.597656
| 29
| 0.411987
| 0.338989
| 1
| 0
| 0
|
no
| null | null |
dnr after sadm
| 5
| 79
| 11.798828
| 70
| 30
| 38.39844
| 148
| 3.599609
| 2.199707
| 0.699951
| 137
| 7.479492
| null | null | null | null | 2
|
<2 mo. follow-up
| 2
| 6
| 1
|
71.13794
|
female
| 0
| 10
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 12
|
under $11k
| 0
| 4,705
| 5,213.4844
| 0
| 7.5
|
white
| 23
| 45
| 0.803955
| 0.68396
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 10
| 61
| 8.398438
| 64
| 28
| 35.89844
| 447.5625
| null | null | 2.5
| 137
| 7.459961
| null | null | null | 3
| 0
|
no(M2 and SIP pres)
| 0
| 1,943
| 0
|
57.681
|
male
| 0
| 7
|
Lung Cancer
|
Cancer
| 1
| 12
|
$25-$50k
| 0
| 2,993
| 3,229.3281
| 0
| 10
|
white
| 31.296875
| 25
| 0.358948
| 0.078995
| 1
| 0
| 0
|
metastatic
| 0.9
| 0.5
|
dnr after sadm
| 1
| 77
| 13.699219
| 120
| 20
| 38.19531
| 272
| 2.599609
| 0.899902
| 0.699951
| 133
| 7.479492
| null | null | null | 0
| 0
|
<2 mo. follow-up
| 0
| 28
| 1
|
78.27795
|
male
| 0
| 8
|
COPD
|
COPD/CHF/Cirrhosis
| 1
| null | null | 0
| 4,964
| 4,387.3906
| 0
| 10.5
|
white
| 20.699219
| 52
| 0.783936
| 0.653931
| 1
| 0
| 0
|
no
| 0.9
| 0.75
|
no dnr
| 8
| 128
| 20.796875
| 64
| 26
| 36.69531
| 180.9375
| 4.299805
| 0.699951
| 2.399902
| 138
| 7.379883
| null | null | null | null | null | null | 3.163574
| 1,941
| 0
|
53.5
|
female
| 0
| 3
|
Lung Cancer
|
Cancer
| 2
| 8
|
under $11k
| 0
| 3,024
| 2,026.7148
| 0
| 11
|
white
| 13.699219
| 11
| 0.78894
| 0.555908
| 1
| 0
| 0
|
metastatic
| 0.75
| 0.1
|
no dnr
| 3
| 98
| 15.5
| 74
| 20
| 36.09375
| null | 3.899902
| 0.5
| 0.899902
| 132
| null | null | null | null | 2
| 0
|
adl>=4 (>=5 if sur)
| 0
| 139
| 1
|
83.17596
|
male
| 1
| 14
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| 6
|
$11-$25k
| 0
| 7,633
| 7,289.1836
| 0
| 4
|
white
| 12.599609
| 32
| 0.860962
| 0.770996
| 1
| 0
| 0
|
no
| 0.5
| 0.5
|
dnr after sadm
| 1
| 67
| 13.5
| 102
| 28
| 38
| 278.25
| 4.399414
| 0.399963
| 1.299805
| 137
| 7.419922
| null | null | null | 1
| 1
|
<2 mo. follow-up
| 1
| 14
| 1
|
76.65399
|
female
| 0
| 4
|
COPD
|
COPD/CHF/Cirrhosis
| 4
| 12
|
$11-$25k
| 0
| 7,349
| 5,321.2695
| 0
| 24
|
white
| 22
| 25
| 0.773926
| 0.639893
| 1
| 1
| 0
|
no
| 0.98
| 0.95
|
no dnr
| 4
| 105
| null | 68
| 24
| 36
| 186
| null | null | 2
| 136
| 7.40918
| null | null | null | null | null |
no(M2 and SIP pres)
| 2.979004
| 673
| 1
|
65.54095
|
female
| 0
| 24
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 10
|
under $11k
| 0
| 19,670
| 19,666.4375
| 4,681.42969
| 9
|
white
| 26.296875
| 46
| 0.777954
| 0.645996
| 1
| 1
| 0
|
no
| 0.3
| 0.1
|
no dnr
| 24
| 60
| 7
| 24
| 36
| 35.39844
| 271.375
| 3.599609
| 0.699951
| 1.399902
| 131
| 7.479492
| null | null | null | 0
| 1
|
no(M2 and SIP pres)
| 1
| 231
| 1
|
60.36697
|
male
| 0
| 15
|
Lung Cancer
|
Cancer
| 2
| 10
|
under $11k
| 0
| 11,616
| 9,475.8438
| 1,852.08984
| 14
|
white
| 20.898438
| 14
| 0.635986
| 0.325989
| 1
| 0
| 0
|
metastatic
| 0.8
| 0.5
|
no dnr
| 15
| 100
| 3.5
| 100
| 20
| 36.19531
| null | 3.199707
| 0.199982
| 0.699951
| 139
| null | null | null | null | 5
| 5
|
no(M2 and SIP pres)
| 5
| 499
| 1
|
73.86694
|
male
| 0
| 17
|
Colon Cancer
|
Cancer
| 1
| 12
|
under $11k
| 0
| 12,604
| 11,720.6719
| 2,091.09961
| 6.333332
|
white
| 12.5
| 17
| 0.856934
| 0.680908
| 1
| 0
| 0
|
metastatic
| 0.99
| 0.5
|
no dnr
| 17
| 71
| 9.298828
| 64
| 16
| 36.59375
| null | 3.699707
| 0.299988
| 0.899902
| 136
| null | null | null | null | 1
| null | null | 1.1669
| 1,474
| 1
|
71.60596
|
female
| 0
| 36
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 8
|
under $11k
| 0
| 102,027
| 87,378.1875
| 15,046.5078
| 29.25
|
white
| 27.199219
| 34
| 0.630981
| 0.527954
| 42
| 0
| 0
|
no
| null | null |
no dnr
| 36
| 68
| 8.898438
| 120
| 28
| 38.19531
| 192.5
| 2.699707
| 2
| 0.699951
| 127
| 7.439453
| null | null | null | null | 1
|
no(M2 and SIP pres)
| 1
| 1,931
| 0
|
70.54095
|
female
| 0
| 16
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 4
| 8
| null | 0
| 31,484
| 25,302.75
| 1,520.14941
| 10.666664
|
white
| 27.398438
| 43
| 0.650879
| 0.55188
| 13
| 1
| 0
|
no
| 0.1
| 0.001
|
dnr after sadm
| 1
| 62
| null | 5.299805
| 32
| 38.19531
| null | null | null | 1.699951
| 133
| null | null | null | null | null | null |
<2 mo. follow-up
| 3.505859
| 42
| 1
|
83.66895
|
female
| 1
| 9
|
COPD
|
COPD/CHF/Cirrhosis
| 3
| 8
|
under $11k
| 0
| 5,823
| 5,288.7266
| 0
| 15
|
white
| 20.597656
| 36
| 0.689941
| 0.522949
| 1
| 0
| 0
|
yes
| null | null |
no dnr
| 9
| 103
| 5.399414
| 112
| 32
| 37.5
| 238.09375
| 3
| 0.199982
| 1
| 141
| 7.40918
| null | null | null | 0
| 2
|
<2 mo. follow-up
| 2
| 9
| 1
|
67.74298
|
female
| 1
| 9
|
COPD
|
COPD/CHF/Cirrhosis
| 4
| 15
|
$11-$25k
| 9
| 12,086
| 8,880.1875
| 2,712.79883
| 36.5
|
white
| 24.097656
| 33
| 0.775879
| 0.642944
| 1
| 0
| 0
|
no
| 0.8
| 0.7
|
no dnr
| 9
| 71
| 7.799805
| 110
| 8
| 37.79688
| 100
| 3.799805
| 0.799927
| 1.299805
| 133
| 7.469727
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 9
| 1
|
57.71899
|
female
| 0
| 7
|
Lung Cancer
|
Cancer
| 1
| 12
|
$11-$25k
| 0
| 4,462
| 4,133.8125
| 513.15967
| 10
|
white
| 15.398438
| 33
| 0.754883
| 0.497986
| 1
| 0
| 0
|
metastatic
| 0.75
| 0.5
|
no dnr
| 7
| 106
| 4.299805
| 76
| 76
| 36.79688
| null | 3.799805
| 0.299988
| 1
| 132
| null | null | null | null | 0
| 0
| null | 0
| 448
| 1
|
68.55597
|
female
| 0
| 9
|
COPD
|
COPD/CHF/Cirrhosis
| 0
| 6
| null | 0
| 4,447
| 4,356.1719
| 2,240.70898
| 10
|
white
| 25.296875
| 37
| 0.775879
| 0.642944
| 1
| 0
| 0
|
no
| 0.7
| 0.55
|
no dnr
| 9
| 75
| 13.298828
| 76
| 24
| 36.29688
| 74.0625
| null | null | 1.199951
| 140
| 7.299805
| null | null | null | 4
| 5
|
no(M2 and SIP pres)
| 5
| 1,924
| 0
|
29.50899
|
female
| 1
| 11
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 16
|
$25-$50k
| 0
| 33,162
| 22,278.0781
| 13,506.4297
| 41
|
white
| 26.097656
| 22
| 0.879883
| 0.837891
| 1
| 0
| 0
|
no
| 0.8
| 0.8
|
dnr after sadm
| 11
| 78
| 6.5
| 104
| 24
| 38.59375
| 100
| 2.899902
| 0.699951
| 0.599976
| 136
| 7.509766
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 11
| 1
|
74.32697
|
male
| 0
| 13
|
Lung Cancer
|
Cancer
| 2
| 8
|
>$50k
| 0
| 7,749
| 7,208.8281
| 3,823.54883
| 7
|
white
| 14.398438
| 21
| 0.735962
| 0.467957
| 1
| 0
| 0
|
metastatic
| 0.8
| 0.2
|
no dnr
| 13
| 97
| 7.299805
| 104
| 20
| 36.39844
| null | 4
| 0.899902
| 1.5
| 133
| null | null | null | null | 1
| 0
|
adl>=4 (>=5 if sur)
| 0
| 77
| 1
|
83.047
|
female
| 0
| 15
|
Colon Cancer
|
Cancer
| 2
| null | null | 0
| 12,151
| 10,807.6719
| 6,059.44922
| 19.666656
|
white
| 32.195313
| 33
| 0.427979
| 0.121994
| 1
| 0
| 0
|
metastatic
| 0.15
| 0.1
|
no dnr
| 15
| 60
| 8.699219
| 58
| 28
| 35.79688
| 142.84375
| 3.099609
| 1.299805
| 1
| 129
| 7.429688
| null | null | null | null | null | null | 3.634766
| 76
| 1
|
66.57397
|
male
| 0
| 6
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| 9
|
under $11k
| 0
| 3,834
| 3,461.3555
| 1,499.34961
| 13
|
white
| 18.898438
| 25
| 0.868896
| 0.782959
| 1
| 0
| 0
|
no
| 0.8
| 0.5
|
no dnr
| 6
| 107
| 12.199219
| 122
| 24
| 36.19531
| 232
| 4.299805
| 0.5
| 1
| 130
| 7.30957
| null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 1,921
| 0
|
67.521
|
male
| 0
| 38
|
COPD
|
COPD/CHF/Cirrhosis
| 3
| 12
| null | 0
| 79,564
| 63,266.0312
| 28,228.3281
| 24.25
|
white
| 35.195313
| 48
| 0.454956
| 0.253967
| 28
| 0
| 0
|
no
| null | null |
no dnr
| 38
| 100
| null | 114
| 40
| 39.29688
| 136.71875
| 2.299805
| 0.699951
| 1.5
| 134
| 7.399414
| null | null | null | null | 3
|
no(M2 and SIP pres)
| 3
| 1,922
| 0
|
71.59497
|
male
| 0
| 15
|
Lung Cancer
|
Cancer
| 2
| 8
|
under $11k
| 0
| 6,543
| 7,237.9766
| 5,261.40625
| 4.666664
|
white
| 14
| 20
| 0.748901
| 0.488953
| 1
| 0
| 0
|
metastatic
| null | null |
dnr after sadm
| 1
| 67
| 4.5
| 43
| 18
| 36.19531
| null | 4.399414
| 0.699951
| 0.699951
| 128
| null | null | null | null | 1
| 0
| null | 0
| 90
| 1
|
68.93396
|
male
| 1
| 75
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 12
|
$11-$25k
| 0
| 121,309
| 89,989.5625
| 87,966.625
| 32
|
white
| 30.699219
| 40
| 0.671997
| 0.575928
| 1
| 0
| 0
|
no
| 0.7
| 0.7
|
dnr after sadm
| 75
| 50
| 13.798828
| 130
| 12
| 38.39844
| 146.125
| 2.099609
| 0.899902
| 0.899902
| 140
| 7.489258
| null | null | null | null | 2
|
adl>=4 (>=5 if sur)
| 2
| 75
| 1
|
69.61499
|
male
| 0
| 5
|
Coma
|
Coma
| 0
| 8
|
$11-$25k
| 89
| 4,395
| 4,332.0352
| 1,491.97949
| 4
|
white
| 18.597656
| 24
| 0.372986
| 0.299988
| 1
| 0
| 0
|
no
| null | null |
dnr after sadm
| 1
| 111
| 12.298828
| 67
| 36
| 39
| 198.5625
| 4.299805
| 0.699951
| 1
| 140
| 7.379883
| null | null | null | null | null |
<2 mo. follow-up
| 2.094238
| 7
| 1
|
78.91595
|
male
| 1
| 23
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 12
|
$25-$50k
| 0
| 16,501
| 12,762.3359
| 10,480.2266
| 11.333328
|
white
| 27.199219
| 58
| 0.695923
| 0.530884
| 1
| 0
| 0
|
no
| null | null |
dnr after sadm
| 1
| 56
| 12.199219
| 77
| 32
| 35.59375
| 323.75
| 3.799805
| 0.299988
| 3.299805
| 132
| 7.529297
| null | null | null | 1
| 5
|
<2 mo. follow-up
| 5
| 23
| 1
|
58.18799
|
male
| 0
| 21
|
MOSF w/Malig
|
ARF/MOSF
| 2
| 12
|
$25-$50k
| 0
| 23,590
| 16,798.2969
| 17,012.75
| 21.333328
|
white
| 25.296875
| 17
| 0.680908
| 0.586914
| 1
| 1
| 0
|
yes
| null | null |
no dnr
| 21
| 107
| 6.399414
| 76
| 24
| 35
| 147.5
| null | null | 0.599976
| 138
| 7.339844
| null | null | null | 6
| 5
|
adl>=4 (>=5 if sur)
| 5
| 187
| 1
|
79.56696
|
male
| 0
| 8
|
Coma
|
Coma
| 2
| 8
|
under $11k
| 89
| 68,703
| 52,034
| 19,768
| 37
|
white
| 20.398438
| 38
| 0.117996
| 0.072998
| 19
| 0
| 0
|
no
| 0.05
| 0.000125
|
dnr after sadm
| 2
| 76
| 7.599609
| 70
| 6
| 38.09375
| 313.3125
| 3.299805
| 5.5
| 2
| 139
| 7.509766
| null | null | null | null | 1
|
<2 mo. follow-up
| 1
| 9
| 1
|
84.75598
|
male
| 1
| 11
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 6
|
under $11k
| 9
| 19,689
| 14,387.6172
| 12,647.9141
| 32.5
|
white
| 22.296875
| 28
| 0.682983
| 0.588989
| 5
| 0
| 0
|
no
| 0.5
| 0.5
|
no dnr
| 11
| 71
| 12.099609
| 106
| 24
| 38.59375
| 280
| 3.599609
| 0.699951
| 1.799805
| 132
| 7.419922
| null | null | null | null | 5
|
<2 mo. follow-up
| 5
| 11
| 1
|
77.23199
|
female
| 0
| 16
|
Lung Cancer
|
Cancer
| 1
| 12
| null | 0
| 10,536
| 9,141.625
| 8,242.52344
| 6.333332
|
white
| 47.296875
| 50
| 0.011
| 0
| 1
| 0
| 0
|
metastatic
| 0.05
| 0.000125
|
no dnr
| 16
| 65
| 20.097656
| 107
| 28
| 35.59375
| 200
| 1.599854
| 1.799805
| 0.899902
| 136
| 7.509766
| null | null | null | null | 5
|
<2 mo. follow-up
| 5
| 19
| 1
|
76.38098
|
male
| 0
| 23
|
Colon Cancer
|
Cancer
| 1
| 9
|
under $11k
| 0
| 20,869
| 15,689.7109
| 14,394.9844
| 19
|
white
| 14.599609
| 16
| 0.827881
| 0.626953
| 1
| 0
| 0
|
metastatic
| null | null |
dnr after sadm
| 16
| 98
| 8.699219
| 82
| 20
| 36.59375
| null | null | null | 1.299805
| 136
| null | null | null | null | 1
| 0
|
<2 mo. follow-up
| 0
| 25
| 1
|
64.05194
|
male
| 0
| 7
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 12
|
$25-$50k
| 0
| 7,054
| 5,307.9805
| 4,175.14844
| 11
|
white
| 11.398438
| 23
| 0.929932
| 0.880981
| 1
| 0
| 0
|
no
| 0.75
| 0.5
|
no dnr
| 7
| 72
| 7.699219
| 83
| 22
| 36.59375
| 372
| 4.099609
| 1.399902
| 1.299805
| 136
| 7.509766
| null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 1,789
| 1
|
80.03595
|
male
| 0
| 9
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 12
|
under $11k
| 0
| 4,391
| 3,785.9277
| 3,023.29883
| 9
|
white
| 16.796875
| 17
| 0.851929
| 0.755981
| 1
| 0
| 0
|
no
| 0.95
| 0.8
|
dnr before sadm
| -1
| 107
| 5.899414
| 78
| 24
| 35.59375
| 380.9375
| 3.599609
| 1.599854
| 1.299805
| 136
| 7.459961
| null | null | null | 0
| 0
| null | 0
| 536
| 1
|
72.02197
|
male
| 0
| 26
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 8
| null | 0
| 76,882
| 51,433.0312
| 56,531.8438
| 29
|
white
| 28.199219
| 55
| 0.626953
| 0.522949
| 12
| 0
| 0
|
no
| 0.8
| 0.6
|
no dnr
| 26
| 63
| 29.097656
| 116
| 46
| 38.89844
| 240.8125
| 3.199707
| 0.799927
| 2.299805
| 133
| 7.399414
| null | null | null | null | 1
|
no(M2 and SIP pres)
| 1
| 1,897
| 0
|
62.543
|
male
| 0
| 10
|
Colon Cancer
|
Cancer
| 1
| 12
|
$11-$25k
| 0
| 5,456
| 4,397.0312
| 3,600.01953
| 10
|
other
| 18.398438
| 20
| 0.80188
| 0.578979
| 1
| 0
| 0
|
metastatic
| null | null |
no dnr
| 10
| 80
| 10.5
| 68
| 28
| 36.19531
| null | null | null | 1
| 134
| 7.489258
| null | null | null | 0
| null | null | 0.4948
| 196
| 1
|
54.31097
|
male
| 0
| 15
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 12
|
>$50k
| 100
| 62,864
| 43,044.2812
| 44,239
| 25.666656
|
white
| 25.097656
| 27
| 0.319946
| 0.205994
| 25
| 0
| 0
|
no
| 0.05
| 0.000125
|
dnr after sadm
| 13
| 72
| 8.298828
| 77
| 36
| 38.69531
| 122
| null | null | 0.599976
| 130
| 7.439453
| null | null | null | null | 1
|
<2 mo. follow-up
| 1
| 17
| 1
|
86.32397
|
female
| 0
| 11
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| null | null | 0
| 8,545
| 6,640.6719
| 6,469.9375
| 20.5
|
white
| 26.898438
| 41
| 0.664917
| 0.567993
| 1
| 0
| 0
|
no
| null | null |
dnr after sadm
| 2
| 56
| 18.296875
| 105
| 24
| 36.19531
| null | 2.799805
| 3.799805
| 1.199951
| 133
| null | null | null | null | null | null |
<2 mo. follow-up
| 3.15625
| 14
| 1
|
61.23199
|
female
| 0
| 21
|
COPD
|
COPD/CHF/Cirrhosis
| 3
| 8
|
under $11k
| 0
| 15,661
| 12,649.1484
| 13,163.9531
| 13
|
white
| 17.796875
| 46
| 0.897949
| 0.829956
| 1
| 0
| 0
|
no
| null | null |
dnr after sadm
| 1
| 65
| 12
| 126
| 24
| 38.09375
| 180
| 4.099609
| 0.399963
| 1
| 136
| 7.519531
| null | null | null | 5
| null |
adl>=4 (>=5 if sur)
| 3.855299
| 198
| 1
|
74.22894
|
female
| 0
| 11
|
CHF
|
COPD/CHF/Cirrhosis
| 4
| 8
| null | 0
| 6,582
| 5,642.9492
| 4,164.71875
| 11
|
white
| 13.099609
| 41
| 0.900879
| 0.833984
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 11
| 101
| 8.798828
| 83
| 28
| 36.29688
| 285.6875
| 4
| 0.5
| 1.299805
| 137
| 7.549805
| null | null | null | 3
| 2
|
no(M2 and SIP pres)
| 2
| 61
| 1
|
71.01996
|
female
| 0
| 10
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| null | null | 0
| 6,888
| 5,454.8125
| 5,304.29688
| 13
| null | 16
| 27
| 0.878906
| 0.79895
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 10
| 69
| 10.398438
| 80
| 24
| 36.29688
| 191.28125
| 3.599609
| 0.699951
| 0.799927
| 138
| 7.379883
| null | null | null | 1
| 1
|
no(M2 and SIP pres)
| 1
| 1,889
| 0
|
72.50696
|
female
| 0
| 8
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 1
| 16
|
$11-$25k
| 0
| 32,917
| 23,600.4844
| 22,444.875
| 42
|
white
| 23.796875
| 32
| 0.55896
| 0.362976
| 6
| 0
| 0
|
no
| null | null |
dnr after sadm
| 7
| 125
| 16.597656
| 135
| 10
| 38.5
| 198
| 2.599609
| 3.699707
| 1.099854
| 138
| 7.479492
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 9
| 1
|
85.90594
|
male
| 1
| 6
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| null | null | 26
| 183,453
| 73,059.375
| 30,414.25
| 24
|
white
| 29.199219
| 68
| 0.344971
| 0.228973
| 95
| 0
| 0
|
no
| null | null |
dnr before sadm
| -88
| 69
| 33.59375
| 74
| 27
| 36.19531
| null | 2.099609
| 11.5
| 2
| 144
| null | null | null | null | null | null |
<2 mo. follow-up
| 2.773438
| 6
| 1
|
59.754
|
male
| 0
| 5
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 0
| 18
|
$25-$50k
| 0
| 2,433
| 2,052.5488
| 2,148.16992
| 6
|
white
| 21.296875
| 22
| 0.771973
| 0.636963
| 1
| 0
| 0
|
no
| 0.95
| 0.05
|
no dnr
| 5
| 77
| 22.097656
| 118
| 24
| 38
| 376.1875
| 2.5
| 0.899902
| 0.699951
| 134
| 7.539062
| null | null | null | 0
| 0
| null | 0
| 1,887
| 0
|
66.34595
|
female
| 0
| 9
|
COPD
|
COPD/CHF/Cirrhosis
| 4
| 12
|
$11-$25k
| 9
| 5,860
| 4,906.1016
| 4,020.01953
| 12
|
white
| 21.597656
| 38
| 0.777954
| 0.645996
| 1
| 0
| 0
|
yes
| 0.7
| 0.5
|
dnr after sadm
| 3
| 66
| 16.097656
| 128
| 28
| 37
| 195.8125
| 3.899902
| 0.5
| 0.799927
| 138
| 7.419922
| null | null | null | 1
| 3
|
no(M2 and SIP pres)
| 3
| 1,887
| 0
|
80.45697
|
male
| 0
| 14
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 18
| null | 9
| 30,311
| 21,456.9531
| 19,580.5312
| 23.666656
|
white
| 23.796875
| 60
| 0.662964
| 0.565918
| 7
| 0
| 0
|
no
| 0.5
| 0.5
|
no dnr
| 14
| 77
| 7.599609
| 112
| 28
| 37.79688
| 228.5625
| null | null | 2.299805
| 150
| 7.509766
| null | null | null | null | null | null | 3.166504
| 1,062
| 1
|
72.83496
|
male
| 0
| 14
|
COPD
|
COPD/CHF/Cirrhosis
| 6
| null | null | 0
| 10,872
| 8,019.3438
| 6,922.66797
| 15
|
white
| 18
| 44
| 0.850952
| 0.753906
| 1
| 1
| 0
|
no
| 0.75
| 0.6
|
dnr after sadm
| 1
| 78
| 23.097656
| 126
| 44
| 37.5
| 247.8125
| 4.299805
| 0.5
| 1.199951
| 139
| 7.439453
| null | null | null | null | null | null | 4.150391
| 1,885
| 0
|
81.51398
|
female
| 0
| 13
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 11
|
under $11k
| 0
| 6,709
| 5,749.2891
| 4,989.08984
| 8.5
|
white
| 23.5
| 45
| 0.75293
| 0.608887
| 1
| 1
| 0
|
no
| 0.5
| 0.3
|
dnr after sadm
| 1
| 61
| 9.699219
| 104
| 24
| 35.59375
| 172
| null | null | 1.299805
| 138
| 7.509766
| null | null | null | 4
| 5
|
no(M2 and SIP pres)
| 5
| 1,884
| 0
|
78.396
|
male
| 0
| 11
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| 14
|
$25-$50k
| 0
| 11,293
| 8,076.2969
| 7,590.22656
| 15.5
|
white
| 18.898438
| 43
| 0.763916
| 0.625
| 1
| 0
| 0
|
yes
| 0.2
| 0.05
|
dnr after sadm
| 1
| 124
| 5.599609
| 114
| 24
| 36.59375
| 200
| 3.799805
| 0.399963
| 1.199951
| 133
| 7.369141
| null | null | null | null | null |
<2 mo. follow-up
| 3.448731
| 12
| 1
|
68.60498
|
male
| 0
| 8
|
Colon Cancer
|
Cancer
| 1
| 10
|
$11-$25k
| 0
| 6,653
| 4,879.6797
| 4,990.33984
| 13.5
|
white
| 15.5
| 8
| 0.829956
| 0.629883
| 1
| 0
| 0
|
metastatic
| 0.95
| 0.8
|
no dnr
| 8
| 99
| null | 61
| 24
| 36.39844
| null | null | null | null | 140
| null | null | null | null | 1
| 0
|
no(M2 and SIP pres)
| 0
| 226
| 1
|
61.47299
|
male
| 0
| 3
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 10
| null | 0
| 3,448
| 2,522.4512
| 2,477.50977
| 29
|
white
| 23.796875
| 23
| 0.820923
| 0.760986
| 1
| 0
| 0
|
no
| 0.9
| 0.9
|
no dnr
| 3
| 80
| 16.796875
| 67
| 20
| 36.29688
| 126.51562
| 4.699219
| 0.599976
| 1.299805
| 138
| 7.319336
| null | null | null | null | 0
| null | 0
| 1,546
| 1
|
56.07397
|
female
| 0
| 40
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 12
|
$11-$25k
| 0
| 165,585
| 126,004.438
| 710,682
| 30.25
|
white
| 37.59375
| 79
| 0.454956
| 0.334961
| 31
| 0
| 0
|
no
| null | null |
dnr after sadm
| 2
| 63
| 29.699219
| 138
| 13
| 38.29688
| 196.65625
| 3.799805
| 13.798828
| 5.099609
| 142
| 7.379883
| null | null | null | null | 0
|
adl>=4 (>=5 if sur)
| 0
| 958
| 1
|
57.42099
|
male
| 0
| 7
|
Colon Cancer
|
Cancer
| 1
| 12
|
$25-$50k
| 0
| 7,708
| 5,461.6094
| 4,998.39844
| 13
|
white
| 15.298828
| 11
| 0.850952
| 0.669922
| 1
| 0
| 0
|
metastatic
| 0.95
| 0.6
|
no dnr
| 7
| 107
| 6.699219
| 101
| 20
| 38.09375
| null | null | null | 1
| 135
| null | null | null | null | 0
| 1
|
no(M2 and SIP pres)
| 1
| 591
| 1
|
54.98398
|
male
| 1
| 11
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 4
| null | null | 100
| 15,063
| 10,865.6094
| 10,276.6094
| 17
|
white
| 36.398438
| 72
| 0.040993
| 0.004
| 1
| 1
| 0
|
no
| 0.1
| 0.001
|
dnr after sadm
| 11
| 139
| 15.699219
| 62
| 30
| 35.39844
| 266.625
| 2.199707
| 21.199219
| 3.599609
| 140
| 7.419922
| null | null | null | null | null |
<2 mo. follow-up
| 4.34375
| 11
| 1
|
75.422
|
male
| 0
| 5
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 8
| null | 0
| 3,121
| 2,554.6328
| 2,038.58984
| 13
|
white
| 15.898438
| 24
| 0.875
| 0.791992
| 1
| 0
| 0
|
no
| 0.9
| 0.5
|
no dnr
| 5
| 123
| 6.199219
| 56
| 24
| 35.69531
| 342.8125
| 4
| 0.799927
| 1.399902
| 138
| 7.509766
| null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 1,875
| 0
|
84.97998
|
female
| 0
| 22
|
Coma
|
Coma
| 2
| null | null | 44
| 13,639
| 11,426.5
| 8,655.96875
| 13.666664
|
white
| 25.199219
| 44
| 0.253967
| 0.186981
| 1
| 0
| 1
|
no
| 0.1
| 0.001
|
no dnr
| 22
| 99
| 26.597656
| 96
| 40
| 39
| null | 3.199707
| 0.599976
| 2.699707
| 141
| null | null | null | null | null | 7
|
<2 mo. follow-up
| 7
| 31
| 1
|
59.45798
|
male
| 0
| 3
|
Lung Cancer
|
Cancer
| 2
| 12
|
$11-$25k
| 0
| 1,553
| 1,255.5518
| 1,230.0791
| 11
|
white
| 16.398438
| 17
| 0.73291
| 0.462952
| 1
| 0
| 0
|
metastatic
| 0.8
| 0.5
|
dnr after sadm
| 1
| 107
| 6.099609
| 24
| 24
| 36.09375
| 457.125
| 4
| 0.299988
| 1.199951
| 136
| 7.639648
| null | null | null | null | 6
|
no(M2 and SIP pres)
| 6
| 107
| 1
|
44.25998
|
female
| 0
| 10
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 15
|
$11-$25k
| 0
| 10,970
| 7,433.0586
| 6,815.72656
| 17
|
other
| 19.597656
| 15
| 0.904907
| 0.869995
| 1
| 0
| 0
|
no
| 0.9
| 0.7
|
no dnr
| 10
| 62
| 11.699219
| 62
| 24
| 36
| 271.375
| 3.099609
| 0.199982
| 0.599976
| 141
| 7.449219
| null | null | null | 2
| null |
no(M2 and SIP pres)
| 1.839
| 1,143
| 1
|
55.55899
|
female
| 0
| 4
|
Lung Cancer
|
Cancer
| 4
| 14
|
$11-$25k
| 0
| 2,302
| 1,812.6016
| 1,555.60938
| 4
|
white
| 6.599609
| 25
| 0.872925
| 0.714966
| 1
| 0
| 0
|
metastatic
| 0.99
| 0.99
|
no dnr
| 4
| 65
| 14
| 65
| 26
| 36.79688
| 309.5
| 4.699219
| 0.699951
| 0.699951
| 135
| 7.429688
| null | null | null | null | null |
no(M2 and SIP pres)
| 2.103516
| 1,872
| 0
|
67.95099
|
female
| 0
| 33
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| 4
|
under $11k
| 0
| 26,722
| 20,023.5625
| 19,698.8281
| 11
|
white
| 38.296875
| 37
| 0.490967
| 0.28894
| 1
| 0
| 0
|
no
| 0.2
| 0.2
|
dnr after sadm
| 1
| 81
| 22.296875
| 110
| 32
| 35.79688
| 147.5
| 2.139648
| 0.799927
| 0.699951
| 134
| 7.40918
| null | null | null | null | 6
|
adl>=4 (>=5 if sur)
| 6
| 82
| 1
|
74.15698
|
male
| 0
| 5
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 8
| null | 0
| 2,651
| 2,370.9727
| 1,644.17969
| 2
|
white
| 16.898438
| 25
| 0.86792
| 0.780884
| 1
| 0
| 0
|
no
| 0.5
| 0.5
|
no dnr
| 5
| 63
| 8.398438
| 60
| 24
| 35.69531
| null | 3.699707
| 0.699951
| 1.399902
| 139
| null | null | null | null | 2
| 0
|
no(M2 and SIP pres)
| 0
| 1,009
| 1
|
75.73999
|
female
| 0
| 50
|
Coma
|
Coma
| 3
| 13
| null | 61
| 62,833
| 44,241.5
| 42,341.375
| 25
|
white
| 20.898438
| 8
| 0.213989
| 0.151978
| 7
| 1
| 0
|
yes
| 0.25
| 0.1
|
dnr before sadm
| -6
| 81
| 12.798828
| 78
| 6
| 36.39844
| 420
| 2.899902
| 0.399963
| 0.699951
| 127
| 7.479492
| null | null | null | null | 1
|
no(M2 and SIP pres)
| 1
| 1,867
| 0
|
69.67596
|
male
| 0
| 10
|
Lung Cancer
|
Cancer
| 3
| 8
| null | 9
| 7,891
| 6,284.1953
| 5,915.72656
| 9.5
|
white
| 21.699219
| 11
| 0.547974
| 0.225983
| 1
| 0
| 0
|
metastatic
| 0.2
| 0
|
dnr after sadm
| 1
| 87
| 11.099609
| 98
| 22
| 36.39844
| null | 3.199707
| 0.199982
| 0.899902
| 133
| null | null | null | null | 1
| 4
|
<2 mo. follow-up
| 4
| 12
| 1
|
60.49597
|
female
| 1
| 10
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 2
| 12
|
$11-$25k
| 0
| 22,177
| 15,144.3828
| 15,246.875
| 45.5
|
white
| 22.699219
| 29
| 0.74292
| 0.595947
| 1
| 0
| 0
|
no
| 0.3
| 0.3
|
dnr after sadm
| 9
| 113
| 21.699219
| 138
| 32
| 38.29688
| 540
| 2.099609
| 1.899902
| 0.799927
| 143
| 7.379883
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 10
| 1
|
86.185
|
female
| 0
| 10
|
COPD
|
COPD/CHF/Cirrhosis
| 3
| 8
|
under $11k
| 0
| 5,999
| 4,802.1836
| 3,841.56836
| 8.5
|
white
| 13.298828
| 22
| 0.837891
| 0.734985
| 1
| 0
| 0
|
no
| 0.5
| 0.4
|
dnr after sadm
| 1
| 66
| 6.699219
| 79
| 22
| 36.79688
| 382.5625
| null | null | 1
| 139
| 7.40918
| null | null | null | 2
| null | null | 1.839
| 606
| 1
|
87.25
|
female
| 0
| 3
|
Coma
|
Coma
| 1
| null | null | 61
| 2,891
| 2,500.2188
| 2,290.41992
| 8
|
white
| 15.099609
| 17
| 0.439941
| 0.365967
| 1
| 0
| 0
|
no
| null | null |
dnr after sadm
| 1
| 93
| 7.799805
| 96
| 24
| 37.5
| 276.1875
| 4
| 0.599976
| 1.299805
| 136
| 7.449219
| null | null | null | null | null |
<2 mo. follow-up
| 2.358398
| 6
| 1
|
70.93994
|
female
| 0
| 10
|
Lung Cancer
|
Cancer
| 2
| 12
| null | 0
| 6,611
| 5,093.9492
| 4,903.25
| 6
|
white
| 27.5
| 26
| 0.424988
| 0.119995
| 1
| 0
| 0
|
metastatic
| null | null |
dnr after sadm
| 1
| 69
| 15
| 73
| 28
| 35
| null | 3.399902
| 0.599976
| 0.599976
| 128
| null | null | null | null | 0
| null |
<2 mo. follow-up
| 0.4948
| 19
| 1
|
66.74597
|
female
| 1
| 5
|
COPD
|
COPD/CHF/Cirrhosis
| 3
| 12
|
under $11k
| 100
| 4,426
| 3,189.6523
| 3,207.23828
| 14
|
white
| 34.195313
| 59
| 0.127991
| 0.028
| 1
| 0
| 0
|
no
| null | null |
dnr after sadm
| 2
| 52
| 11.398438
| 110
| 30
| 36
| 157.125
| 3.099609
| 0.799927
| 0.799927
| 143
| 7.459961
| null | null | null | null | 1
|
<2 mo. follow-up
| 1
| 5
| 1
|
71.745
|
female
| 0
| 4
|
Coma
|
Coma
| 0
| 8
|
under $11k
| 89
| 10,217
| 7,638.0469
| 7,995.45703
| 29
|
white
| 19.296875
| 12
| 0.301941
| 0.230988
| 2
| 0
| 0
|
no
| 0.1
| 0.001
|
no dnr
| 4
| 110
| null | 76
| 12
| 38.59375
| 135.53125
| 3.899902
| 0.699951
| 0.699951
| 136
| 7.5
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 10
| 1
|
69.26196
|
female
| 0
| 11
|
COPD
|
COPD/CHF/Cirrhosis
| 1
| 13
|
$25-$50k
| 26
| 14,092
| 9,658.3047
| 9,800.10938
| 29.5
|
white
| 17.199219
| 41
| 0.822998
| 0.711914
| 1
| 0
| 0
|
no
| 0.9
| 0.85
|
no dnr
| 11
| 129
| 11.898438
| 156
| 10
| 38.59375
| 168
| 4.5
| 0.299988
| 1
| 134
| 7.339844
| null | null | null | null | 0
|
no(M2 and SIP pres)
| 0
| 1,860
| 0
|
76.909
|
male
| 0
| 6
|
Lung Cancer
|
Cancer
| 2
| null | null | 0
| 3,340
| 2,626.6504
| 2,225.76953
| 17
|
white
| 15.699219
| 23
| 0.705933
| 0.421997
| 1
| 0
| 0
|
metastatic
| 0.7
| 0.2
|
no dnr
| 6
| 63
| 6.399414
| 76
| 24
| 36.39844
| null | null | null | 1.399902
| 135
| null | null | null | null | null | null | null | 2.317383
| 320
| 1
|
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.